These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6876568

  • 1. Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia.
    Kraut JA, Shinaberger JH, Singer FR, Sherrard DJ, Saxton J, Miller JH, Kurokawa K, Coburn JW.
    Kidney Int; 1983 May; 23(5):725-30. PubMed ID: 6876568
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
    Jeon HJ, Kwon SH, Kim SW, Shin CS, Park KS, Kim SY, Cho BY, Lee HK.
    Horm Res; 2003 May; 60(3):127-33. PubMed ID: 12931040
    [Abstract] [Full Text] [Related]

  • 3. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia.
    Andress D, Felsenfeld AJ, Voigts A, Llach F.
    Kidney Int; 1983 Sep; 24(3):364-70. PubMed ID: 6645210
    [Abstract] [Full Text] [Related]

  • 4. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.
    Rude RK, Oldham SB, Singer FR.
    Clin Endocrinol (Oxf); 1976 May; 5(3):209-24. PubMed ID: 182417
    [Abstract] [Full Text] [Related]

  • 5. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
    Bellazzi R, Romanini D, Bacchella L, Nai M, Aprile C, Santagostino M, De Vincenzi A.
    Nephron; 1991 May; 57(3):273-82. PubMed ID: 2017266
    [Abstract] [Full Text] [Related]

  • 6. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 May; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 7. Parathyroid hormone and bone histology: response to hypocalcemia in osteitis fibrosa.
    Voigts A, Felsenfeld AJ, Andress D, Llach F.
    Kidney Int; 1984 Feb; 25(2):445-52. PubMed ID: 6727140
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Calcium metabolism in newborn infants. The interrelationship of parathyroid function and calcium, magnesium, and phosphorus metabolism in normal, "sick," and hypocalcemic newborns.
    David L, Anast CS.
    J Clin Invest; 1974 Aug; 54(2):287-96. PubMed ID: 4858778
    [Abstract] [Full Text] [Related]

  • 11. Parathyroid function and magnesium depletion in the rat.
    Anast CS, Forte LF.
    Endocrinology; 1983 Jul; 113(1):184-9. PubMed ID: 6861695
    [Abstract] [Full Text] [Related]

  • 12. Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.
    Goldsmith RS, Furszyfer J, Johnson WJ, Fournier AE, Sizemore GW, Arnaud CD.
    J Clin Invest; 1973 Jan; 52(1):173-80. PubMed ID: 4734166
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid gland function in chronic renal failure.
    Felsenfeld AJ, Llach F.
    Kidney Int; 1993 Apr; 43(4):771-89. PubMed ID: 8479113
    [Abstract] [Full Text] [Related]

  • 14. Evidence of increased parathyroid activity on discontinuation of high-aluminum dialysate in patients undergoing hemodialysis.
    O'Hare JA, Murnaghan DJ.
    Am J Med; 1984 Aug; 77(2):229-32. PubMed ID: 6431809
    [Abstract] [Full Text] [Related]

  • 15. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M.
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [Abstract] [Full Text] [Related]

  • 16. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS, Lee KS, Lee YK, Ma SK, Ko JH, Kim SW, Kim NH, Choi KC.
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [Abstract] [Full Text] [Related]

  • 17. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S, Oprisiu R, Benamar L, Said S, Tataru Albu A, Arsenescu I, el Esper N, Morinière P, Fournier A.
    Nephrologie; 2000 Jun; 21(8):413-24. PubMed ID: 11213385
    [Abstract] [Full Text] [Related]

  • 18. Individualization of dialysate calcium concentration according to baseline pre-dialysis serum calcium.
    Gonzalez-Parra E, Gonzalez-Casaus ML, Arenas MD, Sainz-Prestel V, Gonzalez-Espinoza L, Muñoz-Rodriguez MA, Tabikh A, Egido J, Ortiz A.
    Blood Purif; 2014 Jun; 38(3-4):224-33. PubMed ID: 25531119
    [Abstract] [Full Text] [Related]

  • 19. Azotemic renal osteodystrophy; clinical features and bone pathology.
    Suzuki M, Hirasawa Y.
    Endocrinol Jpn; 1979 Jun; 26(Suppl):85-93. PubMed ID: 467354
    [Abstract] [Full Text] [Related]

  • 20. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
    Fehr T, Garzoni D, Staub T, Binet I, Wüthrich RP.
    Kidney Blood Press Res; 2006 Jun; 29(3):175-81. PubMed ID: 16931896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.